Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain

Gastroenterology Nursing

Volumn 37, Issue 4, 2014, Pages 280-287

  Jelsness Jørgensen, Lars Petter ^a   Bernklev, Tomm ^b,c   Moum, Bjørn ^d  

^a ØSTFOLD UNIVERSITY COLLEGE   (Norway)

^b TELEMARK HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN;

ADULT; CHEMISTRY; COMPLICATION; FECES; FEMALE; HUMAN; HUMAN RELATION; INFLAMMATORY BOWEL DISEASE; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; QUALITY OF LIFE;

ADULT; BIOMARKERS; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERPERSONAL RELATIONS; IRRITABLE BOWEL SYNDROME; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE;

EID: 84905489140     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0000000000000055     Document Type: Article

References (46)

1. Agarwal, N., & Spiegel, B. M. (2011). The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterology Clinics of North America, 40 (1), 11-19. doi: 10.1016/j.gtc.2010.12.013
2. Bager, P., Befrits, R., Wikman, O., Lindgren, S., Moum, B., Hjortswang, H., & Dahlerup, J. F. (2012). Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Alimentary Pharmacology & Therapeutics, 35 (1), 133-141. doi: 10.1111/j.1365-2036.2011.04914.x
3. Beniwal, P., & Harrell, L. (2010). The status of diagnostic markers for inflammatory bowel disease. Current Gastroenterology Reports, 12 (6), 479-484. doi: 10.1007/s11894-010-0145-9
4. Bernklev, T., Jahnsen, J., Aadland, E., Sauar, J., Schulz, T., Lygren, I., & Moum, B. (2004). Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scandinavian Journal of Gastroenterology, 39 (4), 365-373.
5. Bernklev, T., Jahnsen, J., Schulz, T., Sauar, J., Lygren, I., Henriksen, M., ... Moum, B. (2005). Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. European Journal of Gastroenterology & Hepatology, 17 (10), 1037-1045.
6. Bernklev, T., Moum, B., & Moum, T. (2002). Quality of life in patients with inflammatory bowel disease: Translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scandinavian Journal of Gastroenterology, 37 (10), 1164-1174.
7. Bielefeldt, K., Davis, B., & Binion, D. G. (2009). Pain and inflammatory bowel disease. Inflammatory Bowel Diseases, 15 (5), 778-788. doi: 10.1002/ibd.20848
8. Bryant, R. V., van Langenberg, D. R., Holtmann, G. J., & Andrews, J. M. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology & Hepatology, 26 (5), 916-923. doi: 10.1111/j.1440-1746.2011.06624.x
9. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum.
10. Drossman, D. A., Chang, L., Schneck, S., Blackman, C., Norton, W. F., & Norton, N. J. (2009). A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Digestive Diseases and Sciences, 54 (7), 1532-1541. doi: 10.1007/s10620-009-0792-6
11. Gisbert, J. P., Bermejo, F., Perez-Calle, J. L., Taxonera, C., Vera, I., McNicholl, A. G., ... Mate, J. (2009). Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflammatory Bowel Diseases, 15 (8), 1190-1198. doi: 10.1002/ibd.20933
12. Graff, L. A., Vincent, N., Walker, J. R., Clara, I., Carr, R., Ediger, J., & Bernstein, C. N. (2011). A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflammatory Bowel Diseases, 17 (9), 1882-1889. doi: 10.1002/ibd.21580
13. Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., & Tompkins, C. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96 (3), 804-810.
14. Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn'sdisease activity. Lancet, 1 (8167), 514.
15. Hoivik, M. L., Moum, B., Solberg, I. C., Cvancarova, M., Hoie, O., Vatn, M. H., & Bernklev, T. (2012). Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: Results from the IBSEN study. Inflammatory Bowel Diseases, 18 (8), 1540-1549. doi: 10.1002/ibd.21863
16. Irvine, E. J., Feagan, B., Rochon, J., Archambault, A., Fedorak, R. N., Groll, A., & McDonald, J. W. (1994). Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology, 106 (2), 287-296.
17. Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. A. (2011). Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflammatory Bowel Diseases, 17 (7), 1564-1572. doi: 10.1002/ ibd.21530
18. Jelsness-Jorgensen, L. P., Bernklev, T., Henriksen, M., Torp, R., & Moum, B. (2012). Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease. World Journal of Gastroenterology, 18 (5), 445-452. doi: 10.3748/wjg.v18.i5.445
19. Jelsness-Jorgensen, L. P., Bernklev, T., & Moum, B. (2012a). Fatigue and disease-related worries among inflammatory bowel disease patients in remission: Is it a reflection of coexisting IBS-like symptoms? A short report. Journal of Psychosomatic Research, 73 (6), 469-472. doi: 10.1016/j.jpsychores. 2012.08.009
20. Jelsness-Jorgensen, L. P., Bernklev, T., & Moum, B. (2012b). Quality of life in patients with inflammatory bowel disease: Translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS). Quality of Life Research, 21 (9), 1671-1676. doi: 10.1007/s11136-011-0081-7
21. Keohane, J., O'Mahony, C., O'Mahony, L., O'Mahony, S., Quigley, E. M., & Shanahan, F. (2010). Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation? American Journal of Gastroenterology, 105 (8), 1788, 1789-1794; quiz 1795. doi: 10.1038/ajg.2010.156
22. Koloski, N. A., Boyce, P. M., Jones, M. P., & Talley, N. J. (2012). What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Quality of Life Research, 21 (5), 829-836. doi: 10.1007/ s11136-011-9985-5
23. Loge, J. H., & Kaasa, S. (1998). Short Form 36 (SF-36) Health Survey: Normative data from the general Norwegian population. Scandinavian Journal of Social Medicine, 26 (4), 250-258.
24. Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006). Functional bowel disorders. Gastroenterology, 130 (5), 1480-1491. doi: 10.1053/j.gastro.2005.11.061
25. Matricon, J., Meleine, M., Gelot, A., Piche, T., Dapoigny, M., Muller, E., & Ardid, D. (2012). Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 36 (11/12), 1009-1031. doi: 10.1111/apt.12080
26. Miehsler, W., Weichselberger, M., Offerlbauer-Ernst, A., Dejaco, C., Reinisch, W., Vogelsang, H., ... Moser, G. (2008). Which patients with IBD need psychological interventions? A controlled study. Inflammatory Bowel Diseases, 14 (9), 1273-1280. doi: 10.1002/ibd.20462
27. Minderhoud, I. M., Oldenburg, B., Wismeijer, J. A., van Berge Henegouwen, G. P., & Smout, A. J. (2004). IBS-like symptoms in patients with inflammatory bowel disease in remission: Relationships with quality of life and coping behavior. Digestive Diseases and Sciences, 49 (3), 469-474.
28. Monnikes, H. (2011). Quality of life in patients with irritable bowel syndrome. Journal of Clinical Gastroenterology, 45 (Suppl.), S98-S101. doi: 10.1097/MCG.0b013e31821fbf44
29. Moradkhani, A., Beckman, L. J., & Tabibian, J. H. (2013). Healthrelated quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors. Journal of Crohn's and Colitis, 7 (6), 467-473. doi: 10.1016/j.crohns.2012.07.012
30. Naliboff, B. D., Kim, S. E., Bolus, R., Bernstein, C. N., Mayer, E. A., & Chang, L. (2012). Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: A structural equation modeling analysis. American Journal of Gastroenterology, 107 (3), 451-459. doi: 10.1038/ajg.2011.377
31. Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27 (3) (Suppl.), S217-S232.
32. Quigley, E. M., Abdel-Hamid, H., Barbara, G., Bhatia, S. J., Boeckxstaens, G., De Giorgio, R., ... Tzeuton, C. (2012). A global perspective on irritable bowel syndrome: A consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. Journal of Clinical Gastroenterology, 46 (5), 356-366. doi: 10.1097/MCG.0b013e318247157c
33. Romkens, T. E., van Vugt-van Pinxteren, M. W., Nagengast, F. M., van Oijen, M. G., & de Jong, D. J. (2011). High prevalence of fatigue in inflammatory bowel disease: A case control study. Journal of Crohn's and Colitis, 5 (4), 332-337. doi: 10.1016/j.crohns.2011.02.008
34. Schirbel, A., Reichert, A., Roll, S., Baumgart, D. C., Buning, C., Wittig, B., ... Sturm, A. (2010). Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World Journal of Gastroenterology, 16 (25), 3168-3177.
35. Siegel, C. A., & MacDermott, R. P. (2009). Is chronic pain an extraintestinal manifestation of IBD? Inflammatory Bowel Diseases, 15 (5), 769-771. doi: 10.1002/ibd.20844
36. Simren, M., Axelsson, J., Gillberg, R., Abrahamsson, H., Svedlund, J., & Bjornsson, E. S. (2002). Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. American Journal of Gastroenterology, 97 (2), 389-396. doi: 10.1111/j.1572-0241.2002.05475.x
37. Sipponen, T., Bjorkesten, C. G., Farkkila, M., Nuutinen, H., Savilahti, E., & Kolho, K. L. (2010). Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment. Scandinavian Journal of Gastroenterology, 45 (3), 325-331. doi: 10.3109/00365520903483650
38. Solberg, I. C., Lygren, I., Jahnsen, J., Aadland, E., Hoie, O., Cvancarova, M., ... Moum, B. (2009). Clinical course during the first 10 years of ulcerative colitis: Results from a population-based inception cohort (IBSEN Study). Scandinavian Journal of Gastroenterology, 44 (4), 431-440. doi: 10.1080/00365520802600961
39. Solberg, I. C., Vatn, M. H., Hoie, O., Stray, N., Sauar, J., Jahnsen, J., & Lygren, I. (2007). Clinical course in Crohn's disease: Results of a Norwegian population-based ten-year follow-up study. Clinical Gastroenterology & Hepatology, 5 (12), 1430-1438. doi: 10.1016/j.cgh.2007.09.002
40. Sperber, A. D., Shvartzman, P., Friger, M., & Fich, A. (2007). A comparative reappraisal of the Rome II and Rome III diagnostic criteria: Are we getting closer to the "true" prevalence of irritable bowel syndrome? European Journal of Gastroenterology and Hepatology, 19 (6), 441-447. doi: 10.1097/MEG.0b013e32801140e2
41. Spiegel, B. M., Gralnek, I. M., Bolus, R., Chang, L., Dulai, G. S., Naliboff, B., & Mayer, E. A. (2005). Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointestinal Endoscopy, 62 (6), 892-899. doi: 10.1016/j.gie.2005. 08.016
42. Tkalcic, M., Hauser, G., & Stimac, D. (2010). Differences in the health-related quality of life, affective status, and personality between irritable bowel syndrome and inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology, 22 (7), 862-867. doi: 10.1097/MEG.0b013e3283307c75
43. Wadlund, D. L. (2012). Meeting the challenge of IBS. Journal of Nurse Practitioners, 37 (5), 22-30; quiz 30-21. doi: 10.1097/01.npr.0000413481.44379. 24
44. Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43 (1), 29-32.
45. Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30 (6), 473-483.
46. Zambroski, C. H., Moser, D. K., Bhat, G., & Ziegler, C. (2005). Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. European Journal of Cardiovascular Nursing, 4 (3), 198-206. doi: 10.1016/j.ejcnurse.2005.03.010